Summary: Mature oligodendrocytes—cells essential for healthy brain function and for producing the myelin sheath that insulates axons—can undergo a remarkably prolonged death process after severe DNA damage, surviving up to 45 days after injury. This contrasts sharply with younger oligodendrocyte lineage cells, which die within hours to a day. The discovery reveals a previously unrecognized route of cell persistence and suggests new directions for treating age-related brain damage and demyelinating diseases such as multiple sclerosis.
Using advanced live-tissue imaging and a precise phototoxic tool to target single cells, Dartmouth researchers mapped how oligodendrocytes at different maturation stages respond to the same lethal insult. The results indicate that maturation fundamentally changes the timing and mechanism of cell death, with important implications for strategies aimed at preserving myelin, promoting remyelination, and protecting brain function during aging and disease.
Key Facts:
- Extended survival in mature cells: Mature oligodendrocytes can persist for weeks—up to 45 days—after fatal DNA damage, far longer than younger precursor and differentiating cells.
- Distinct death mechanisms by maturity: Cells at different stages of the oligodendrocyte lineage die by different molecular and temporal pathways, indicating that a single therapeutic approach may not protect all cell stages.
- Relevance to neurodegenerative disease: Understanding delayed death and dysfunctional myelin in mature oligodendrocytes could reshape treatment concepts for demyelinating conditions such as multiple sclerosis and for aging-related white matter loss.
Source: Dartmouth College
Overview
Oligodendrocytes are the central nervous system cells that wrap axons with a lipid-rich myelin sheath, enabling fast, efficient transmission of electrical signals between neurons. When oligodendrocytes are damaged or die, myelin production stops and sheaths can break down, disrupting neural communication and contributing to loss of motor function, sensation, and cognitive abilities. Age and diseases like multiple sclerosis (MS) are major contributors to oligodendrocyte injury and demyelination.
Previously, scientists generally assumed that damaged oligodendrocytes follow a rapid, programmed cell death pathway (apoptosis). However, the Dartmouth team found that mature oligodendrocytes follow a different trajectory: instead of immediate apoptosis, these cells enter a protracted, controlled decline marked by delayed DNA-damage signatures and altered subcellular markers, and they eventually degenerate only after weeks.
“Mature cells undertake a pathway that is still controlled, but not the classical programmed cell-death pathway,” said Robert Hill, assistant professor of biological sciences and corresponding author. He emphasized that this discovery likely reflects changes that occur as oligodendrocytes mature and accumulate damage over a lifetime, and that these changes can alter how cells respond to the same injury.
Project lead and first author Timothy Chapman, who carried out this work as a PhD candidate in Hill’s lab and is now a postdoctoral researcher, noted the practical implications: therapeutic strategies must account for differences between young and mature oligodendrocytes. “Young cells go one way and old cells go another,” Chapman said. “To protect or restore myelin effectively, we will likely need age- or stage-specific interventions—possibly a dual approach that separately targets newly formed and long-lived oligodendrocytes.”
The researchers adapted a living-tissue model previously reported by the team that lets them ablate a single oligodendrocyte and then observe the surrounding tissue’s response. In young-tissue equivalents, neighboring cells quickly replace lost myelin; in tissue resembling a 60-year-old brain, neighboring cells often fail to respond, leaving axons denuded. That model, combined with high-resolution long-term imaging, allowed the team to track cell fate over weeks rather than hours.
For controlled, single-cell damage the team used a photon-based device developed by Hill’s lab, nicknamed 2Phatal, to induce DNA damage in individual oligodendrocytes. They compared results to a conventional demyelination method using the toxin cuprizone. Differentiating oligodendrocytes and precursor cells activated rapid, caspase-dependent cell death pathways after injury, but mature cells did not activate the same executioner caspase and instead showed delayed degeneration with distinct DNA-damage markers and disruptions in poly-ADP-ribose localization.
The observation that mature oligodendrocytes remain present—albeit dysfunctional—for many weeks raises new clinical questions: is prolonged persistence of a damaged, nonfunctional myelin sheath beneficial or harmful? Hill described the situation as akin to “garbage sitting on the axon” that might block repair or nutrient exchange. Deciding whether to promote survival or accelerate removal of these dysfunctional cells will depend on disease context and will require deeper understanding of the delayed cell-death mechanism.
This research highlights the importance of considering oligodendrocyte maturation in the design of therapies for demyelinating diseases and age-related myelin loss. By revealing divergent death mechanisms across the lineage, the study suggests targeted strategies that either protect vulnerable young oligodendrocytes or address the unique vulnerabilities of long-lived mature cells to preserve neural function.
The published article, “Oligodendrocyte Maturation Alters the Cell Death Mechanisms That Cause Demyelination,” appeared in the Journal of Neuroscience on March 27, 2024.
Funding: This work was supported by the National Institutes of Health (R01NS122800), the Esther A. and Joseph Klingenstein Fund, the Simons Foundation, and the Department of Biological Sciences at Dartmouth.
About this neuroscience research news
Author: Morgan Kelly
Source: Dartmouth College
Contact: Morgan Kelly – Dartmouth College
Image credit: Neuroscience News
Original Research: Closed access. “Oligodendrocyte Maturation Alters the Cell Death Mechanisms That Cause Demyelination” by Robert Hill et al., Journal of Neuroscience.
Abstract
Oligodendrocyte Maturation Alters the Cell Death Mechanisms That Cause Demyelination
Myelinating oligodendrocytes die in human disease and early in aging. Despite this, the mechanisms that underlie oligodendrocyte death are not fully resolved, and it is unclear whether those mechanisms change as oligodendrocyte lineage cells differentiate and mature.
Using intravital imaging, single-cell ablation, and cuprizone-mediated demyelination in both female and male mice, the study shows that oligodendrocyte maturation determines the dynamics and mechanisms of cell death. After phototoxic single-cell damage, oligodendrocyte precursor cells undergo programmed cell death within hours, differentiating oligodendrocytes die over several days, and mature oligodendrocytes take weeks to die. While cells at each stage ultimately die, their temporal dynamics and morphological features differ markedly.
Cuprizone treatment triggered a caspase-3–dependent rapid death in differentiating oligodendrocytes, whereas mature oligodendrocytes did not activate this executioner caspase. Instead, mature cells showed delayed death characterized by DNA damage and disrupted poly-ADP-ribose localization. These results indicate that oligodendrocyte maturation plays a central role in determining how a cell responds to the same insult, a factor that should be considered when designing strategies to prevent cell death, preserve myelin, and support remyelination in demyelinating conditions.